Victoria P. Werth, MD, discusses how litifilimab’s 52-week AMETHYST findings inform treatment expectations and timely reassessment of persistent cutaneous lupus symptoms.
|Articles|April 13, 2016
Zolav Proven Effective in Treating Acne
Author(s)Laurie Toich, Assistant Editor
A new antibiotic has been shown to treat severe acne without the adverse side effects of isotretinoin.
Advertisement
In a new study published by Journal of Drug Design, Development and Therapy, the drug Zolav was proven to be an effective new antibiotic for treating acne.
Researchers have found that Zolav has antioxidant-like properties and has lower toxicity to cells than other current treatments.
Chief Executive Officer of Boulos and Cooper Pharmaceuticals Ramiz Boulos stated in a press release, “these are promising results and provide persons affected by acne with a new treatment option that is low risk.”
The current treatment for severe cases of acne is isotretinoin.
This vitamin A derivative is effective in treating acne, but it has many adverse side effects. The most severe adverse side effect is birth defects in pregnant women.
Zolav will reach the market in only a couple of years, according to a press release.
Advertisement
Related to this article
In an interview with Pharmacy Times, Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania and chief of dermatology at the Philadelphia VA Medical Center, discusses why meaningful improvement extends beyond skin clearance and how response timing affects patients with difficult-to-control disease.
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
As psychedelic therapies advance through clinical development, pharmacists should prepare for potential roles in their safe, evidence-based integration into patient care.
How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
Advertisement
Advertisement
Trending on Pharmacy Times
1
Preparing Pharmacists for Psychedelic Medicine
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
Beyond Skin Clearance: What Litifilimab Could Mean for Cutaneous Lupus Care
5